genedrive (LON:GDR) Hits New 52-Week High Following Insider Buying Activity

genedrive plc (LON:GDR)’s stock price reached a new 52-week high during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 1.55 and last traded at GBX 1.40, with a volume of 10964131 shares trading hands. The stock had previously closed at GBX 1.40.

Specifically, insider Gino Miele purchased 700,000 shares of the stock in a transaction on Friday, August 28th. The stock was bought at an average price of GBX 1 per share, with a total value of £7,000.

genedrive Price Performance

The company has a quick ratio of 5.52, a current ratio of 0.99 and a debt-to-equity ratio of -120.48. The stock’s 50 day moving average price is GBX 1.21 and its two-hundred day moving average price is GBX 1.12. The stock has a market cap of £22.48 million, a price-to-earnings ratio of -1.77 and a beta of 0.99.

genedrive Company Profile

genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.